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Abstract
Introduction: Many intensive care unit (ICU) patients describe pain and other adverse feelings that may impact
long-term psychological morbidity. Sympathetically mediated palmar skin conductance variability is related to
emotionally induced perspiration and correlates with pain levels in the perioperative setting but has not been
studied in ICU patients.
Methods: Twenty non-intubated and 20 intubated general ICU patients were included in this observational study.
Patients were monitored with the MED-STORM Pain Monitoring System®. The number of skin conductance
fluctuations per second (NSCF) was measured in parallel with bedside observation during one hour of intensive
care, including rest, procedures and patient-staff interactions. Arousal-agitation level was monitored with the motor
activity assessment scale (MAAS). Pain was monitored with the numeric rating scale (0 to 10) in patients able to
communicate or by observation in patients unable to communicate.
Results: In non-intubated patients, NSCF increased with increasing stimulation/pain but also with higher MAAS
(P = 0.002). An interaction effect was found, with increased NSCF response to stimulation/pain with increasing
MAAS (P < 0.001).
In intubated patients, NSCF increased significantly with increasing stimulation/pain (P < 0.001). In contrast to non-
intubated patients, no difference in NSCF between MAAS levels was found for any given degree of stimulation in
intubated patients.
Conclusions: In critically ill patients, NSCF may be more useful evaluating emotional distress rather than pain
alone. It needs to be assessed whether NSCF monitoring is clinically useful and whether controlling emotional
distress with the aid of such monitoring may impact on patient care and outcomes.
Introduction
Clinical practice guidelines for sedation and analgesia
have been developed in order to achieve and maintain
comfort and safety in critically ill patients [1]. Still,
many intensive care unit (ICU) patients remember hav-
ing anxiety and unrelieved pain when interviewed after
the ICU stay [2,3]. Such negative memories have been
associated with adverse long-term outcomes [4].
Emotional stress is associated with increased activity in
the sympathetic nervous system. This increased activity
includes the activation of palmar sweat glands [5].
Sweat gland activation in response to emotional stress is
believed to originate in parts of the limbic system [5].
Via brainstem activation, cholinergic transmission in para-
vertebral ganglia increases and eventually leads to activa-
tion of muscarinic sweat gland receptors [5]. Increased
palmar moisture leads to altered electrical conductance of
the palm [5-7]. Basal skin moisture level, skin quality and
surrounding temperature vary in different individuals and
settings, making absolute palmar skin conductance highly
individual [7]. In contrast, skin conductance variability -
mediated by intermittent palmar sweat release and reup-
take - more directly mirrors ongoing sympathetic nerve
activity to palmar sweat glands, as measured with neuro-
graphy [5]. Peripherally administered vasopressors and
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inotropes, such as epinephrine, norepinephrine or dobuta-
mine, do not pass the blood-brain barrier and have little
effect on muscarinic receptors. For these reasons they are
likely to have little impact on palmar sweat gland
activation.
In order to measure ongoing palmar sweat gland acti-
vation in response to emotional stress, a measure of skin
conductance variability (number of skin conductance
fluctuations, NSCF) has recently been developed and
evaluated [7,8]. In a study of intraoperative stimulation,
NSCF changed faster and with greater sensitivity during
stimulation than did more classical indicators of intrao-
perative pain, such as blood pressure or heart rate [9].
NSCF has also been found to correlate with postoperative
patient ratings of pain [10,11].
To our knowledge, skin conductance variability has not
been evaluated as a measure of pain in critically ill adults.
We performed this observational study in order to explore
the relationship between skin conductance variability
(referred to as NSCF) and varying degrees of stimulation,
pain and level of arousal-agitation in a mixed ICU patient
population.
Materials and methods
Design, inclusion and exclusion criteria
This prospective observational study was performed at
the general ICU, a mixed medical and surgical ICU at
Karolinska University Hospital Solna, Stockholm. The
study was approved by the local Ethical Review Board in
Stockholm (Regionala Etikprövningsnämnden I Stock-
holm). Forty critically ill patients age above 17 years, were
included (20 non-intubated and 20 intubated). Patients
were excluded if they were diagnosed with neuro- or myo-
pathy, were receiving neuromuscular blocking agents, or
were treated with atropine or glycopyrrolate the same day,
as such treatments or conditions could potentially make
clinical assessment difficult or affect muscarinic sweat
gland receptor activity. Written informed consent from
the participants or their closest relatives was obtained.
Skin conductance variability monitoring
Skin conductance variability was monitored during one
hour of routine daytime intensive care nursing and treat-
ment. A skin conductance monitor, Med-Storm Pain
Monitoring System® (MED-STORM Innovation AS,
Oslo, Norway) was used for this purpose. Three single
use Ag/AgCl electrodes (MED-STORM Innovation AS,
Oslo, Norway) were attached to the palmar surface of the
patient’s hand: on the thenar eminence (current elec-
trode), hypothenar eminence (measurement electrode)
and just below the second and third digits (reference
electrode). The hand least likely to be moved was chosen
to minimize movement artifacts. Skin conductance
variability was measured by alternating current at 66 Hz
and an applied voltage of 50 mV.
Skin conductance variability was measured as the num-
ber of skin conductance fluctuations per second (NSCF).
The cutoff for identifying skin conductance fluctuations
was set with skin conductance troughs and peaks of an
amplitude > 0.02 microsiemens (μS), as in previous
studies of NSCF in the perioperative setting [9-11]. The
measurement window - the sampling time from which
the mean NSCF value was calculated - was 15 seconds.
The refreshing time, the time a new measurement win-
dow was analyzed, was one second. Incoming data were
displayed on-line on a laptop connected to the monitor
via a standard serial port and stored for subsequent ana-
lysis. Monitoring was not blinded so that the observers
could see the skin conductance curve and the values of
NSCF and note when artifacts disturbed registration.
Clinical assessment
Parallel with NSCF monitoring, the level of stimulation/
pain and arousal-agitation were assessed.
Stimulation/pain assessment
For awake and communicative patients, pain level on
the 11-point numeric rating scale (NRS 0 to 10) [12]
was asked for and noted during procedures. For patients
unable to communicate, the patient’s behavior at rest
and during procedures was observed.
Observations of stimulation/pain were categorized in
four groups:
A. No stimulation. The patient was lying undisturbed,
without any observed or reported pain (see D).
B. Mild stimulation without observed or reported pain.
The patient was being spoken to or procedures, such as
gentle washing, were performed or the patient made
slight movements without observed or reported pain.
C. Potentially painful stimulation without observed or
reported pain. The patient did not report or show signs
of pain but was exposed to any of the following proce-
dures or conditions:
1. Needle stick.
2. Turning of the patient.
3. Suction of the mouth, hypopharynx or endotra-
cheal tube.
4. Unsynchronized with the ventilator or abnormal
breathing pattern.
5. Dressing of wound.
D. High pain rating or overt expression of pain in rest
or during stimulation/procedure. The patient expressed
pain verbally (NRS above 3). If the patient could not rate
pain with the NRS the following signs were considered
indicative of pain or discomfort:
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1. Facial grimacing.
2. Moaning or groaning.
3. Localizing painful area, withdrawing from touch
or resisting potentially painful movement or
procedure.
Arousal/agitation assessment
Patients’ arousal/agitation level was assessed with the
Motor Activity Assessment Scale (MAAS) scale (Table 1)
[13], the scale used in our general ICU.
Data collection
During the hour of monitoring, typical procedures were
washing, turning the patient, physiotherapy and in some
cases also invasive procedures, such as intravenous line
insertion or bronchoscopy. At the time of the event or
procedure, an on-line mark on the laptop monitor was
made and the NRS or observed stimulation/pain level and
MAAS level was noted. Comments describing the event or
procedure were made for each observation. The mean
NSCF value, representing the 15-second window at the
time of the event, was later extracted for analysis. When
the skin conductance signal quality was below 80% (as a
result of distortion of the reference signal or a change of
the integrity of the measured signal) or connection was
temporarily lost, the event was registered as “artifact”, as
were situations when the patient moved the NSCF mea-
surement hand.
Statistical analysis
Unlike the non-intubated patients, the intubated patients
could not speak and more often received sedative and opi-
ate infusions. The intubated and non-intubated patients
were, therefore, analyzed separately. Random-effects
regression models were used to analyze NSCF over differ-
ent pain and MAAS levels. In the regression models, sti-
mulation and MAAS were introduced as numeric
variables. Statistical significance level was set at P < 0.01.
Analyses were performed with Stata version 12 (StataCorp,
College Station, TX, USA).
Results
Patient demographics are presented in Table 2. In total,
the non-intubated patients contributed 715 registrations
and the intubated patients 735 registrations. Room tem-
peratures during the study ranged between 22° and 24°C.
Patient temperatures ranged between 37.4° and 40.0°C.
Sedative and analgesic drugs were more frequently used
in intubated than in non-intubated patients (Table 3).
The MAAS score ranged between 2 and 5 for non-
intubated patients and between 0 and 4 in the intubated
patients. Fourteen of the 20 non-intubated patients rated
their pain with the NRS.
In non-intubated patients, higher levels of stimulation/
pain were associated with higher NSCF (P = 0.002) for all
MAAS levels except MAAS 2 (Figure 1, Table 4). There
was significant interaction between stimulation and
MAAS level (P < 0.001), with an increased NSCF response
to stimulation with increasing MAAS (Figure 1, Table 5).
For intubated patients, increasing stimulation/pain was
associated with increased NSCF (P < 0.001) at all MAAS
levels (Figure 2, Table 3). In contrast to non-intubated
patients, increasing MAAS level was not significantly asso-
ciated with an increase in NSCF (P = 0.64) (Figure 2).
Artifacts precluded adequate registration 83 times
(11.3% of observations) in the intubated patients and
206 times (28.8% of observations) in the non-intubated
patients.
Discussion
To our knowledge, this is the first study evaluating skin
conductance variability in critically ill adult patients. The
main findings were that NSCF generally increased with
the degree of stimulation/pain, an observation common
for both patient groups.
The highest NSCF readings were found in non-intu-
bated patients with high MAAS level and with overt
expression of pain. A higher degree of arousal or agitation
was associated with a stronger NCSF response to stimula-
tion/pain (Figure 1). This finding can be interpreted as
similar to that of higher subjective pain rating during
Table 1 Motor Activity Assessment Scale (MAAS) [14]
Score Description Definition
0 Unresponsive Does not move with noxious stimuli
1 Responsive only to noxious
stimuli
Open eyes, raises eyebrows or turns head toward stimulus; moves limbs with noxious stimulus
2 Responsive to touch or
name
Open eyes, raises eyebrows or turns head toward stimulus when touched or name is loudly spoken
3 Calm and cooperative No external stimulus in required to elicit movement; adjusts sheets or clothes purposefully, follows commands
4 Restless and cooperative No external stimulus in required to elicit movement; picks at sheets or tubes, uncovers self, follows commands
5 Agitated No external stimulus in required to elicit movement, attempts to sit up or moves limbs out of bed, does not
consistently follow commands (for example, will lie down when asked to but soon reverts back to attempts to
sit up or move limbs out of bed)
6 Dangerously agitated,
uncooperative
No external stimulus in required to elicit movement; pulls at tubes or catheters, thrashes side to side, strikes at
staff, tries to climb out of bed, does not calm down when asked.
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states of elevated stress or anxiety [14]. Previous studies of
NSCF in the anesthesia or postoperative setting have
focused on detecting pain [9-11]. While postoperative
patients might experience pain as an isolated negative per-
ception, it is likely that ICU patients that are awake (that
is, MAAS > 2) are aware of their severity of illness and
being in the ICU. Such awareness may potentially contri-
bute to emotional stress [15] and subsequent NSCF
response to stimulation/pain.
In the intubated patients, NSCF values were lower
overall, but still with increasing NSCF with increasing sti-
mulation. MAAS level change did not significantly alter
the NSCF response to stimulation or pain (P = 0.64).
One difference between study groups, besides endotra-
cheal intubation, was that the intubated patients received
more sedatives and analgesics (Table 3). As a desired
pharmacological effect, these drugs sedate the patient,
potentially affecting awareness of the critical situation.
Our interpretation of the differences between the two
groups is that ICU patients that are awake and increas-
ingly aware, aroused or agitated are more reactive to pain
than those calm or less rousable.
We find it of some interest that intubated patients with
MAAS 3 and without any on-going activity or stimula-
tion had a mean NSCF of 0.28 (Table 5), a level asso-
ciated with high pain rating in a previous study of NSCF
and postoperative pain [11]. In that study, NSCF above
0.2 was associated with an NRS pain rating of 4 and
above [11]. It may be that these intubated and awake
patients were in greater discomfort or pain than what
was apparent from the clinical observation. However,
only four patients contributed to these data, MAAS 3
without ongoing activity/stimulation (of which one
patient contributed with 13 of 18 observations), which
precludes firm conclusion of this finding.
The number of registrations when artifacts were present
was relatively high (28.8% in non-intubated patients and
11.3% in intubated patients). In some patients the electro-
des fell off due to movement and stretching of the wires,
or due to excessive sweating. Electrode adhesion problems
and movement artifacts may possibly be reduced with bet-
ter electrodes and wrapping of the hand [16].
Generally, we interpret our study findings as that NSCF
appears to mirror distress rather than pain alone, which is
a limitation from a pain monitoring perspective. Instead,
skin conductance variability monitoring might be a means
of monitoring discomfort or distress in ICU patients. The
level of comfort and sedation, as well as sedative choice
may affect memories from the ICU [17,18], and thereby
potentially impact psychological well-being and long-term
quality of life [18,19]. Whether distress indicated with skin
conductance variability monitoring is deleterious for
patients’ perception of and memories from the ICU stay
and subsequent psychological outcome deserves further
study, with longer-term skin conductance monitoring and
possibly including pharmacological and non-pharmacolo-
gical interventions.
Limitations
A major limitation in our study was our classification of
stimulation/pain in non-communicating patients. At the
outset of the study, we did not have a validated Swedish
pain monitoring instrument available. We used a non-
standardized way of assessing pain in these patients,
namely by observing facial grimacing, body movements
or sounds as indicators of pain in patients unable to
communicate verbally, which may have led to some
degree of misclassification. Recently, pain monitoring
instruments for poorly communicating patients have
been developed and validated [20,21], with the Critical
Care Pain Observational Tool now also available in
Swedish [22].
Another limitation is that the study observers were
not blinded for online NSCF levels. The monitor was
new for the observers and we felt that information dis-
played was important in this pilot study. Online infor-
mation included electrode status and signal quality, the
time marker and online “notepad”. For a more formal
validation study, including specificity and sensitivity ana-
lyses, a validated pain assessment tool or a composite
Table 2 Patient demographics
Intubated Non-intubated
Age; mean (SD) 60 (16) 55(18)
sex;
Female 2 7
Male 18 13
ICU day*; median (range) 3 (1 to 13) 2 (1 to 19)
Diagnosis group (n);
Medical 4 6
Surgical 4 4
Trauma 4 6
Sepsis 8 4
*Day of registration.
Table 3 Sedation and/or analgesia at the time of NSCF
registration
Sedation/analgesia Intubated
n = 20
Non-Intubated
n = 20
Opiates infusion 10 0
intermittent 6 5
Bensodiazepines infusion 9 0
intermittent 1 0
Propofol infusion 6 0
intermittent 4 0
Clonidine 6 3
Epidural 2 5
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pain and agitation score would be appropriate to use, as
well as blinding of skin conductance levels.
Finally, while NSCF has been shown to decrease
with analgesic treatment of pain in postoperative
patients [11], our protocol did not include evaluation
of changes in NSCF in response to sedation or analge-
sia due to emotional stress or pain. Such evaluation
would have been valuable and is warranted in future
studies.
Conclusions
Palmar skin conductance variability increases with
increasing stimulation in critically ill patients. In non-
intubated patients increasing MAAS levels are associated
with increased NSCF responses to stimulation/pain. This
interaction is not seen during mechanical ventilation
and sedation. Future studies of skin conductance varia-
bility are needed, to investigate if skin conductance
variability monitoring can aid ICU clinicians in the gen-
eral management of emotional stress due to pain and
other adverse feelings, and if such monitoring and sub-
sequent interventions are associated with improved
patient outcomes.
Key messages
• Skin conductance variability as measured as NSCF,
increases with increasing stimulation/pain in criti-
cally ill ICU patients.
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Figure 1 Skin conductance variability (NSCF) in relation to stimulation and Motor Activity Assessment Scale, non-intubated patients.
Table 4 NSCF in relation to MAAS and degree of stimulation in non-intubated patients
MAAS 2
n = 30
MAAS 3
n = 589
MAAS 4
n = 92
MAAS 5
n = 4
No stimulation
n = 77
0,01
n = 14
0.07
n = 98
0,12
n = 5
No
observation
Mild stimulation
n = 165
0.08
n = 10
0.10
n = 256
0.18
n = 73
No
observation
Potentially painful stimulation
n = 53
0.30
n = 2
0.21
n = 66
0.46
n = 7
No
observation
Expression of pain
n = 112
0.03
n = 4
0.21
n = 169
0.50
n = 7
0.48
n = 4
Cross-tabulated mean (above) and count (below).
Günther et al. Critical Care 2013, 17:R51
http://ccforum.com/content/17/2/R51
Page 5 of 7
• In less sedated and non-intubated ICU patients,
increasing arousal and agitation increases the NSCF
response to stimulation.
• Further research is warranted to investigate potential
clinical benefits of NSCF monitoring in ICU patients.
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MAAS 0
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Figure 2 Skin conductance variability (NSCF), in relation to stimulation and Motor Activity Assessment Scale, intubated patients.
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